Publications

2025

Investigation of radiomic features on MRI images to identify extraprostatic extension in prostate cancer.

Computer methods and programs in biomedicine.259():108528-[DOI] 10.1016/j.cmpb.2024.108528.[PMID] 39615194.

PubMed·Publisher's Site

2025

Protein kinase D1 mitigation against etoposide induced DNA damage in prostate cancer is associated with increased α-Catenin.

The Prostate.85(2):156-164[DOI] 10.1002/pros.24812.[PMID] 39428693.

PubMed·Publisher's Site

2024

MRI-based radiomic features for identifying recurrent prostate cancer after proton radiation therapy.

Journal of applied clinical medical physics.25(3):e14293-[DOI] 10.1002/acm2.14293.[PMID] 38409947.

1 citations·PubMed·Publisher's Site

2023

Can magnetic resonance imaging differentiate muscle invasion (T2) and lamina propria invasion (T1) urothelial carcinoma of the bladder? A systematic review and meta-analysis of Vesical Imaging-Reporting and Data System accuracy.

Current urology.17(4):262-267[DOI] 10.1097/CU9.0000000000000214.[PMID] 37994331.

1 citations·PubMed·Publisher's Site

2023

Does care fragmentation in patients with bladder cancer lead to worse outcomes?

Urologic Oncology: Seminars and Original Investigations.41(3):147.e7-147.e14[DOI] 10.1016/j.urolonc.2022.10.028.[PMID] .

PubMed·Publisher's Site

2023

Extramural venous invasion: a novel magnetic resonance imaging biomarker for adverse pathology in bladder cancer.

American journal of clinical and experimental urology.11(2):185-193[DOI] .[PMID] 37168940.

PubMed·Publisher's Site

2023

Genetic mutations in smoking-associated prostate cancer.

The Prostate.83(13):1229-1237[DOI] 10.1002/pros.24554.[PMID] 37455402.

1 citations·PubMed·Publisher's Site

2023

Glomerular hyperfiltration is a predictor of adverse outcomes following major urologic oncology surgery.

International urology and nephrology.55(2):229-239[DOI] 10.1007/s11255-022-03400-4.[PMID] 36318406.

1 citations·PubMed·Publisher's Site

2023

Magnetic resonance imaging radiomic features for recurrent prostate cancer following proton radiation therapy-A pilot study.

Urologic oncology.41(3):145.e1-145.e5[DOI] 10.1016/j.urolonc.2022.10.007.[PMID] 36496342.

1 citations·PubMed·Publisher's Site

2023

Metastatic prostate cancer is associated with distinct higher frequency of genetic mutations at diagnosis.

Urologic oncology.41(11):455.e7-455.e15[DOI] 10.1016/j.urolonc.2023.09.014.[PMID] 37838503.

1 citations·PubMed·Publisher's Site

2023

MRI-based nomograms and radiomics in presurgical prediction of extraprostatic extension in prostate cancer: a systematic review.

Abdominal radiology (New York).48(7):2379-2400[DOI] 10.1007/s00261-023-03924-y.[PMID] 37142824.

8 citations·PubMed·Publisher's Site

2023

Natural history, and impact of surgery and radiation on survival outcomes of men diagnosed with low-grade prostate cancer at ≤ 55 years of age: a 25-year follow-up of > 60,000 men.

International urology and nephrology.55(2):295-300[DOI] 10.1007/s11255-022-03363-6.[PMID] 36171482.

7 citations·PubMed·Publisher's Site

2023

Potential role for protein kinase D inhibitors in prostate cancer.

Journal of molecular medicine (Berlin, Germany).101(4):341-349[DOI] 10.1007/s00109-023-02298-4.[PMID] 36843036.

1 citations·PubMed·Publisher's Site

2023

The Bivalent Bromodomain Inhibitor MT-1 Inhibits Prostate Cancer Growth.

Cancers.15(15):-[DOI] 10.3390/cancers15153851.[PMID] 37568667.

PubMed·Publisher's Site

2023

The geriatric nutritional risk index predicts complications after nephrectomy for renal cancer.

International braz j urol : official journal of the Brazilian Society of Urology.49(1):97-109[DOI] 10.1590/S1677-5538.IBJU.2022.0380.[PMID] 36512458.

8 citations·PubMed·Publisher's Site

2023

The impact of socioeconomic status on the survival of men with early-onset prostate cancer.

American journal of clinical and experimental urology.11(2):146-154[DOI] .[PMID] 37168939.

1 citations·PubMed·Publisher's Site

2023

Urinary stone disease burden is increased in patients with cognitive impairment.

American journal of clinical and experimental urology.11(3):249-257[DOI] .[PMID] 37441445.

PubMed·Publisher's Site

2022

3JC48-3 (methyl 4′-methyl-5-(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)-[1,1′-biphenyl]-3-carboxylate): a novel MYC/MAX dimerization inhibitor reduces prostate cancer growth

Cancer Gene Therapy.29(11):1550-1557[DOI] 10.1038/s41417-022-00455-4.[PMID] .

PubMed·Publisher's Site

2022

Complications after neoadjuvant chemotherapy and radical cystectomy for patients with bladder cancer: A propensity score matched analysis.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada.():-[DOI] 10.5489/cuaj.7952.[PMID] 36473472.

3 citations·PubMed·Publisher's Site

2022

Diagnostic accuracy of vesical imaging-reporting and data system (VI-RADS) in suspected muscle invasive bladder cancer: A systematic review and diagnostic meta-analysis.

Urologic oncology.40(2):45-55[DOI] 10.1016/j.urolonc.2021.11.008.[PMID] 34895996.

16 citations·PubMed·Publisher's Site

2022

Inter-reader reliability of the vesical imaging-reporting and data system (VI-RADS) for muscle-invasive bladder cancer: a systematic review and meta-analysis.

Abdominal radiology (New York).47(12):4173-4185[DOI] 10.1007/s00261-022-03669-0.[PMID] 36112202.

14 citations·PubMed·Publisher's Site

2022

The Geriatric Nutritional Risk Index Predicts Postoperative Outcomes in Bladder Cancer: A Propensity Score-Matched Analysis.

The Journal of urology.207(4):797-804[DOI] 10.1097/JU.0000000000002342.[PMID] 34854753.

25 citations·PubMed·Publisher's Site

2021

An Indirect Comparison of Newer Minimally Invasive Treatments for Benign Prostatic Hyperplasia: A Network Meta-Analysis Model.

Journal of endourology.35(4):409-416[DOI] 10.1089/end.2020.0739.[PMID] 32962442.

32 citations·PubMed·Publisher's Site

2021

Intracorporeal versus extracorporeal urinary diversion following robot-assisted radical cystectomy: a meta-analysis, cumulative analysis, and systematic review.

Journal of robotic surgery.15(3):321-333[DOI] 10.1007/s11701-020-01174-4.[PMID] 33222043.

17 citations·PubMed·Publisher's Site

2021

MRI and CT bladder segmentation from classical to deep learning based approaches: Current limitations and lessons.

Computers in biology and medicine.134():104472-[DOI] 10.1016/j.compbiomed.2021.104472.[PMID] 34023696.

22 citations·PubMed·Publisher's Site

2021

Pathology grade influences competing mortality risks in elderly men with prostate cancer.

Urologic oncology.39(8):493.e1-493.e7[DOI] 10.1016/j.urolonc.2020.12.004.[PMID] 33353870.

1 citations·PubMed·Publisher's Site

2021

Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: What about the Negatives?

Radiology.298(1):E57-[DOI] 10.1148/radiol.2020202870.[PMID] 33141006.

3 citations·PubMed·Publisher's Site

2020

A Systematic Review and Meta-Analysis of Methods Used to Reduce Infectious Complications Following Transrectal Prostate Biopsy.

Urology.144():21-27[DOI] 10.1016/j.urology.2020.06.005.[PMID] 32569659.

3 citations·PubMed·Publisher's Site

2020

Comparative efficacy of apalutamide darolutamide and enzalutamide for treatment of non-metastatic castrate-resistant prostate cancer: A systematic review and network meta-analysis.

Urologic oncology.38(11):826-834[DOI] 10.1016/j.urolonc.2020.03.022.[PMID] 32605736.

25 citations·PubMed·Publisher's Site

2020

Meta-analysis and systematic review of intermediate-term follow-up of prostatic urethral lift for benign prostatic hyperplasia.

International urology and nephrology.52(6):999-1008[DOI] 10.1007/s11255-020-02408-y.[PMID] 32065331.

15 citations·PubMed·Publisher's Site

2020

Re: Antibiotic Prophylaxis for the Prevention of Infectious Complications following Prostate Biopsy: A Systematic Review and Meta-AnalysisA. Pilatz, K. Dimitropoulos, R. Veeratterapillay, Y. Yuan, M. I. Omar, S. MacLennan, T. Cai, F. Bruyère, R. Bartoletti, B. Köves, F. Wagenlehner, G. Bonkat and B. Pradere J Urol 2020; 204: 224-230.

The Journal of urology.204(6):1349-1350[DOI] 10.1097/JU.0000000000001332.[PMID] 32830995.

1 citations·PubMed·Publisher's Site

2020

Symptomatic Pituitary Metastasis as Initial Manifestation of Renal Cell Carcinoma: Case Report and Review of Literature.

Case reports in endocrinology.2020():8883864-[DOI] 10.1155/2020/8883864.[PMID] 32908722.

3 citations·PubMed·Publisher's Site

2019

Protein kinase D1 induces G1-phase cell-cycle arrest independent of Checkpoint kinases by phosphorylating Cell Division Cycle Phosphatase 25.

The Prostate.79(9):1053-1058[DOI] 10.1002/pros.23807.[PMID] 30958903.

4 citations·PubMed·Publisher's Site

2013

Novel 3D co-culture model for epithelial-stromal cells interaction in prostate cancer.

PloS one.8(9):e75187-[DOI] 10.1371/journal.pone.0075187.[PMID] 24073251.

45 citations·PubMed·Publisher's Site

2007

Clinical significance of benign glands at surgical margins in robotic radical prostatectomy specimens.

Urology.69(6):1112-6[DOI] .[PMID] 17572197.

16 citations·PubMed·Publisher's Site

2007

Protein kinase D1: a protein of emerging translational interest.

Frontiers in bioscience : a journal and virtual library.12():3757-67[DOI] .[PMID] 17485336.

49 citations·PubMed·Publisher's Site

Show More